- CA19-9/Sialyl Lewis A Antibody (121SLE)
- Novus Biologicals, a Bio-Techne Brand
- Pricing InfoSupplier PageView Company Product Page
- NBP2-45188-0.1mg
- 0.1 mg (also 0.02 mg)
- Immunohistochemistry, Immunohistochemistry-Paraffin
- Unconjugated
- 10 mM PBS with 0.05% BSA
- Human
- CA19-9/Sialyl Lewis A
- IgM Kappa
- 121SLE
- Mouse
- Precipitin lines obtained after immuno-diffusion using MAb 116-NS-19-9 and mucins isolated from an ovarian cyst of a Lewis A+B- patient (0Le)
- Monoclonal
- Protein L or PEG purified
- Novus Biologicals, a Bio-Techne Brand
- 0.2 mg/ml
- Primary Antibodies
- 400 kDa
- Tumor Biomarkers
- Store at 4C
Specifications/Features
Available conjugates: Unconjugated
Specificity: CA19-9, a carbohydrate epitope expressed on a high MW (400kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens